The Oxford University vaccine is already in the final phases of clinical trials, phase three, and one of the world's leading pharmaceutical firms, which was mentioned already, AstraZeneca is already manufacturing hundreds of millions of doses to be ready by the end of the year, where in comparison, according to ClinicalTrials.gov, your trial at Dalhousie is not even recruiting patients yet for phase two trials and the company that you're partnered with, CanSino, hasn't sold a single product outside China.
With respect, how is it possible that Dalhousie and CanSino will be able to outrace Oxford and AstraZeneca to a vaccine?